John Wilson

Prevalence, impact and specialised treatment of urinary incontinence in women with chronic lung disease

BM Button, AE Holland, MS Sherburn, J Chase, JW Wilson, AT Burge

Journal article  |  2019  |  Physiotherapy

The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites

Elena K Schneider, Rachel M McQuade, Vincenzo C Carbone, Felisa Reyes-Ortega, John W Wilson, Brenda Button, Ayame Saito, Daniel P Poole, Daniel Hoyer, Jian Li, Tony Velkov

Journal article  |  2018  |  ERJ OPEN RESEARCH

Ivacaftor-lumacaftor and ivacaftor are two new breakthrough cystic fibrosis transmembrane conductance modulators. The interactions..

Collagen-induced resistance to glucocorticoid anti-mitogenic actions: a potential explanation of smooth muscle hyperplasia in the asthmatic remodelled airway

JV Bonacci, T Harris, JW Wilson, AG Stewart

Journal article  |  2003  |  British Journal of Pharmacology

Differential inhibition of thrombin- and EGF-stimulated human cultured airway smooth muscle proliferation by glucocorticoids

R Vlahos, KS Lee, E Guida, DJ Fernandes, JW Wilson, AG Stewart

Journal article  |  2003  |  Pulmonary Pharmacology and Therapeutics

A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction

JJ Presneill, T Harris, AG Stewart, JF Cade, JW Wilson

Journal article  |  2002  |  American Journal of Respiratory and Critical Care Medicine

Determinants and targets in progressive airways disease

AG Stewart, JW Wilson, GP Anderson, CP Page

Journal article  |  2001  |  Pulmonary Pharmacology and Therapeutics